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1. Supplementary Figures 
 
Supplementary Figure 1. NanoPOMP flow system. 
 
 
Supplementary Figure 2. Workflow for filter-aided sample preparation (FASP).  
 
 






Supplementary Figure 4. UV-Vis absorption spectrum of TiO2 NPs suspension in water. Source data are provided as 




Supplementary Figure 5. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 40-





Supplementary Figure 6. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 43-






Supplementary Figure 7. EIC and product-ion (MS/MS) spectra of unmodified (top) and modified (bottom) peptide 61-






Supplementary Figure 8. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 100-






Supplementary Figure 9. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 106-





Supplementary Figure 10. EIC and product-ion (MS/MS) spectra of unmodified (top) and modified (bottom) peptide 
112-117 from VKOR. 
 
 
Supplementary Figure 11. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 






Supplementary Figure 12. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 





Supplementary Figure 13. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 
196-204 from VKOR. 
 
 
Supplementary Figure 14. EIC and product-ion (MS/MS) spectra of modified (top) and unmodified (bottom) peptide 







Supplementary Figure 15. Circular dichroism spectrum of membrane protein VKOR. Black line is for the blank. Red 
line represents 2 μM VKOR in water with 5% DDM detergent. Green line represents 2 μM VKOR in water with 5% DDM 




Supplementary Figure 16. VKOR enzymatic activity assay. Y axis represents fluorescence intensity of KH2 with VKOR 




Supplementary Figure 17. MS sequence coverage example of hGLUT1 in bottom-up proteomics obtained by 
























































Supplementary Figure 26. SASA change upon ligand binding. (a) Cartoon of outward open and inward open models 
with binding to Mal and CyB, respectively. Red dot represents the binding ligand. (b) NanoPOMP modification extent 
difference of [CyB bound state – Mal bound model state] shown on hGLUT1 3D structure. Orange represents increased 





2. Supplementary Tables 
Supplementary Table 1. Optimization of several conditions for NanoPOMP. All volumes are in μL. 
 0% 2% 4% 5% 6% 8% 10% 13% 15% 
VKOR-
liposome 
2.5  2.5  2.5 2.5 2.5 2.5 2.5 2.5 2.5 
TiO2 5.0  5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Tris buffer 42.5 41.5 40.5 40 39.5 38.5 37.5 36 35 
Acetone 0 1 2 2.5 3 4 5 6.5 7.5 
 
Supplementary Table 2. NanoPOMP experiments of hGLUT1 in liposome. All volumes are in μL. 
 A B C D E 
GLUT1-
liposome 
5.0 5.0 5.0 5.0 5.0 
TiO2 5.0 5.0 5.0 5.0 5.0 
Acetone 0 3 3 3 3 
Tris buffer 40 37 32 32 32 
Substrates -- -- 5 (glucose) 5 (Mal) 5 (CyB) 
 
















62-65 520.277 536.271 1.581E8 8.196E7 3.414 W 
73-81 854.408 870.403 1.758E8 1.859E7 9.559 M 
140-152 681.852 689.850 2.132E7 9.798E6 31.49 M 
140-143 509.243 525.238 6.835E7 1.319E8 65.86 M 
144-150 344.679 322.689 4.674E8 1.248E7 2.601 E 
191-194 479.286 495.281 6.595E7 9.750E6 12.88 F 
232-244 491.565 496.895 8.890E7 5.553E7 38.45 M 
232-251 788.037 793.368 1.055E7 1.672E7 16.31 M 
299-308 559.796 537.801 1.124E9 4.268E6 0.378 D 
380-388 476.250 484.248 6.380E7 2.363E7 27.02 W 
 















13-21 830.480 846.477 2.711E6 4.731E6 63.57 M 
62-65 520.276 552.206 2.307E8 5.139E6 1.608 W 
68-72 530.307 552.303 3.077E7 3.867E6 12.01 F 
73-81 854.408 870.403 6.875E6 1.298E7 62.94 M 
99-102 490.269 506.264 3.563E7 7.835E6 18.02 M 
102-104 350.207 366.202 1.180E8 2.449E7 17.51 F 
105-110 310.177 318.175 9.440E6 8.756E6 48.35 M 
120-124 618.352 634.347 1.193E7 6.513E6 35.40 M 
123-127 303.192 311.189 2.427E8 7.431E6 2.971 R 
20 
 
140-143 509.243 525.238 1.793E7 1.800E7 54.00 M 
170-174 289.170 297.173 5.347E6 2.304E6 12.53 F 
175-180 635.306 651.300 4.693E7 3.570E6 7.069 M 
191-194 479.286 495.281 1.165E8 1.070E8 52.13 F 
195-199 526.360 542.355 5.373E7 1.715E8 23.85 Not sure 
229-244 461.495 465.493 1.672E7 2.198E8 7.068 M 
232-244 491.565 496.895 9.340E7 1.464E7 13.54 M 
232-251 788.037 793.368 5.74E7 2.660E8 17.75 M 
252-260 373.230 378.502 2.830E7 2.710E7 48.69 M 
261-263 408.212 424.207 4.378E8 8.409E7 16.36 F 
269-273 313.703 321.700 1.245E8 2.450E7 16.44 not sure 
287-291 563.330 579.313 1.250E6 2.232E6 63.11 F 
299-308 559.796 567.791 2.571E8 6.073E6 2.30 Not sure 
337-341 276.679 284.676 2.644E7 3.814E6 12.60 I 
376-379 483.260 499.255 1.011E8 1.636E7 13.82 F 
379-388 549.785 557.782 7.239E6 6.014E6 26.14 W 
380-388 476.254 484.251 8.159E7 3.423E7 29.55 W 
389-395 794.481 838.471 7.456E5 7.474E8 0.100 E 
435-437 392.254 408.249 2.174E8 11.26E7 33.95 F 
442-444 378.239 394.234 9.617E7 3.263E7 24.88 F 
445-447 426.239 442.234 2.486E7 1.323E7 34.68 F 
461-467 694.341 738.330 1.366E7 3.091E9 0.440 D 
 
Supplementary Table 5. Information of labeled peptide from TiO2-isopropanol FPOP of hGLUT1. 
Peptide Modification Ratio (%) Location 
62-65 23.23 Extra-membrane 
73-81 5.433 TM2 
191-194 52.13 TM6 
195-199 23.85 TM6 
229-244 7.068 Extra-membrane 
232-251 5.884 Extra-membrane 
299-308 0.658 TM8 
309-320 0.551 TM8 
376-379 55.39 TM10 
379-388 26.14 TM10 
380-388 29.55 TM10 
389-395 0.1 Extra-membrane 
445-447 14.76 TM12 
461-467 0.44 Extra-membrane 
 
